Thus, it is tempting to speculate that CD1d-dependent regulation of CD36 functions in cancer cells could contribute to modulate their survival, proliferation and/or metastatic potential and consequently influence disease progression and response to treatment. This evidence concerns the gene CD1D and cancer.